Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-02
1997-05-20
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3135
Patent
active
056312830
ABSTRACT:
The administration of sialidase inhibitors or sialic acid is useful as me for treating inflammatory conditions and for intervening in infectious processes in instances where pathogenicity of the disease-causing organism is increased by microbial surface interaction with host cells.
REFERENCES:
patent: 5374655 (1994-12-01), Kashem et al.
STN compound [28283-68-3] 1994.
Ogura et al. 1987, Carbohydrate Resib. vol. 167 pp. 77-87.
Noble et al 1982 Eur. J. Biochem 126 pp. 543-548.
Ippolito et al 1994 120CA:261339X.
Cross Alan S.
Gomatos Peter
Stamatos Nicholas
Wright Daniel G.
Moran John Francis
The United States of America as represented by the Secretary of
Travers Russell
LandOfFree
Use of sialic acid or antibodies to sialidase as anti-infectious does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sialic acid or antibodies to sialidase as anti-infectious, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sialic acid or antibodies to sialidase as anti-infectious will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724396